Jupiter Life Line Hospitals Ltd (NSE: JLHL, BSE: 543980) is a Mumbai, Maharashtra-based company in the Hospitals and Healthcare Centers industry. With a market capitalisation of ₹9,392 Cr, it ranks #614 by market cap among the 6,197 Indian listed companies on FinBizNet, and #13 of 46 in Hospitals and Healthcare Centers. At ₹290.00 (as of 16 Nov 2026), the share price is 14.7% below its 52-week high of ₹340.00 and 24.3% above its 52-week low of ₹233.40. The share price is down 8.2% over one year and down 9.9% over three months.
| Current Price | ₹290.00 |
|---|---|
| Market Cap | ₹9,392 Cr |
| NSE Symbol | JLHL |
| BSE Code | 543980 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Hospitals and Healthcare Centers |
| P/E Ratio | 48.5 |
| Return on Equity | 13.73% |
| Return on Assets | 7.44% |
| 52-Week Range | ₹233.40 – ₹340.00 |
| 1-Year Price Change | -8.2% |
| 3-Month Price Change | -9.9% |
| Beta (1Y) | -0.05 |
| Dividend Yield | 0.07% |
| Headquarters | Mumbai, Maharashtra |
| Website | www.jupiterhospital.com |
| Revenue | ₹457 Cr |
|---|---|
| Net Profit | ₹56 Cr |
| Net Margin | 12.3% |
| EPS (Basic) | ₹1.72 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Jupiter Life Line Hospitals Ltd reported revenue of ₹457 Cr in Q2 FY27, up 16.0% from ₹394 Cr in Q2 FY26 and up 11.1% from ₹411 Cr in Q1 FY27. It posted a net profit of ₹56 Cr for the quarter, against a net profit of ₹57 Cr in Q2 FY26 (down 1.9%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹327 Cr (Q4 FY25) to ₹457 Cr (Q2 FY27). The company was profitable in each of these 7 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q2 FY27 | ₹457 Cr | ₹56 Cr | 12.3% |
| Q1 FY27 | ₹411 Cr | ₹38 Cr | 9.1% |
| Q4 FY26 | ₹388 Cr | ₹49 Cr | 12.6% |
| Q3 FY26 | ₹365 Cr | ₹43 Cr | 11.6% |
| Q2 FY26 | ₹394 Cr | ₹57 Cr | 14.6% |
| Q1 FY26 | ₹348 Cr | ₹44 Cr | 12.6% |
| Q4 FY25 | ₹327 Cr | ₹45 Cr | 13.7% |
Consolidated figures (₹ crore, XBRL filings).
Promoters held 40.91% of Jupiter Life Line Hospitals Ltd's shares as of Sept 2026, unchanged from Sept 2025. Delivery averaged 50.9% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).
Jupiter Life Line Hospitals Limited, a multi-specialty hospital, provides health care services under the Jupiter brand in India. The company offers treatments in the areas of bariatric surgery, breast care center, cardiac surgery, cardiology, chest medicine, dental care, dermatology, endocrinology and diabetes, ENT, gastroenterology, general surgery and minimal access surgery, hematology and BMT, HPB and surgical gastroenterology, infectious diseases, internal medicine, interventional radiology, mental health, nephrology, neurology, neurosurgery, nutrition and dietetics, Obs and gynecology, oncology, ophthalmology, organ transplant, orthopedics, pediatrics, pain clinic, plastic and cosmetic surgery, rehabilitation, rheumatology, robotic knee replacement, robotic surgery, TAVI/TAVR, and urology. It also operates hotel under the Fortune Park Lake City Hotel name in Thane. The company was incorporated in 2002 and is based in Mumbai, India.
1. Healthcare Services-This segment provides healthcare services. 2. NA-NA 3. NA-NA 4. NA-NA
1. Medical and Healthcare Services-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | ₹1,23,712 Cr | 63 | 21.50% | ₹7,615 Cr | +11.6% |
| Max Healthcare Institute Ltd | ₹91,978 Cr | 63.9 | 14.33% | ₹2,569 Cr | -16.6% |
| Manipal Health Enterprises Ltd | ₹89,110 Cr | 88.4 | — | ₹3,399 Cr | — |
| Aster Dm Healthcare Limited (Asterdm) | ₹63,041 Cr | 97.6 | 10.07% | ₹2,829 Cr | +4.3% |
| Fortis Healthcare Ltd. | ₹58,283 Cr | 55.1 | 11.01% | ₹2,735 Cr | -25.1% |
| Global Health Ltd (Medanta) | ₹38,422 Cr | 69.7 | 15.03% | ₹1,469 Cr | +16.2% |
| Narayana Hrudayalaya Limited | ₹37,907 Cr | 46.2 | 19.85% | ₹2,844 Cr | +2.8% |
| Krishna Institute Of Medical Science (KIMS) | ₹29,056 Cr | 120.6 | 9.72% | ₹1,344 Cr | +0.2% |
| Jupiter Life Line Hospitals Ltd | ₹9,392 Cr | 48.5 | 13.73% | ₹457 Cr | -8.2% |
Listed by market capitalisation. Ratios are shown for context only.
Jupiter Life Line Hospitals Ltd is trading at ₹290.00, with a market capitalisation of ₹9,392 Cr.
Jupiter Life Line Hospitals Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).
Jupiter Life Line Hospitals Ltd has a P/E of 48.5 and a return on equity of 13.73%.
Jupiter Life Line Hospitals Ltd is listed on the NSE under the symbol JLHL and on the BSE under the scrip code 543980.
Jupiter Life Line Hospitals Ltd's share price is down 8.2% over one year and down 9.9% over three months. Its 52-week range is ₹233.40 to ₹340.00.
In Q2 FY27, Jupiter Life Line Hospitals Ltd reported revenue of ₹457 Cr and net profit of ₹56 Cr, with basic EPS of ₹1.72 (consolidated, parsed from the company's exchange filing).
Jupiter Life Line Hospitals Ltd reported revenue of ₹457 Cr in Q2 FY27, up 16.0% from ₹394 Cr in Q2 FY26 and up 11.1% from ₹411 Cr in Q1 FY27.
Promoters held 40.91% of Jupiter Life Line Hospitals Ltd's shares as of Sept 2026, unchanged from Sept 2025.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.